Inovio's planned Phase 2/3 Covid-19 vaccine trial on partial hold to answer FDA questions, company says

  • 📰 CNN
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 95%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Inovio's planned Phase 2/3 Covid-19 vaccine trial has been put on partial hold to answer questions from the FDA, biotechnology company says.

From CNN's Stephanie Halasz in London and Pierre Bairin in Paris

Coronavirus admissions at intensive care units in the Provence-Alpes Côte d'Azur region of southern France have tripled since the beginning of September, according to official statistics. The number of Covid-19 ICU patients in Paris went up from 169 to 339 in the same period. In France overall, the figure went up to 1,112 by September 27 compared to 418 at the start of the month, the health authority says.

The situation in the south of France will be reviewed after seven days, and could be extended by a further week if there is no improvement, the French Health Minister tweeted.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

why would the FDA put a hold on Inovio INO-4800 vaccine delivering device when the vaccine has been proven to be safer and more effective then any others, its because Big Pharma has corrupted the officials at the FDA. This screams of foul play. InovioPharma inoviolt

BREAKING: Democrat Party activists pretending to report the news are intentionally neglecting to inform the public of any wrongdoing by key Democrat leadership figures and their family. ONLY PRESIDENT TRUMP IS TARGETED BY THE MEDIA.

Since cnn won't report...

horrible

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 4. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인